Zheng Xing Xing Ye Ri Bao·2025-10-09 09:03Market Overview - The biopharmaceutical sector experienced a slight decline of 0.12% on October 9, with Rongchang Biopharmaceutical leading the drop [1] - The Shanghai Composite Index closed at 3933.97, up 1.32%, while the Shenzhen Component Index closed at 13725.56, up 1.47% [1] Stock Performance - Notable gainers in the biopharmaceutical sector included: - ST Sihuan (code: 000518) with a closing price of 2.39, up 4.82% [1] - Wanzhe Co. (code: 000534) with a closing price of 15.93, up 4.46% [1] - Baipu Sais (code: 301080) with a closing price of 61.67, up 3.54% [1] - Rongchang Biopharmaceutical (code: 688331) saw a significant decline of 11.47%, closing at 103.47 [2] Trading Volume and Capital Flow - The biopharmaceutical sector saw a net outflow of 122 million yuan from institutional investors, while retail investors contributed a net inflow of 156 million yuan [2] - The trading volume for Rongchang Biopharmaceutical was 126,100 shares, with a transaction value of 1.329 billion yuan [2] Individual Stock Capital Flow - Main capital inflows were observed in: - Wantai Biopharmaceutical (code: 603392) with a net inflow of 50.12 million yuan [3] - Zhifei Biological (code: 300122) with a net inflow of 34.08 million yuan [3] - Notable outflows included: - Zhifei Biological with a retail net outflow of 4.29 million yuan [3] - Shenzhou Cell (code: 688520) with a retail net outflow of 3.30 million yuan [3]